Details

session_id
sess_SDA-2026-04-11-gap-debate-20260410-110745-72201cc8
round_number
4
agent_persona
persona-synthesizer
agent_backend
minimax:MiniMax-M2.7
action
synthesize
tokens_used
603
persona_id
persona-synthesizer
Raw fields (1)
content

# SCFA Brain Concentrations & HDAC Inhibition - Synthesis Analysis

```json
{
  "ranked_hypotheses": [
    {
      "rank": 1,
      "id": "H3",
      "title": "GPR109A as Primary Mechanism for Microglial Reprogramming",
      "target": "HCAR2 (GPR109A/Niacr1)",
      "composite_score": 0.835,
      "mechanistic_plausibility": 0.80,
      "evidence_strength": 0.85,
      "novelty": 0.75,
      "feasibility": 0.85,
      "therapeutic_potential": 0.90,
      "druggability": 0.90,
      "safety_profile": 0.75,
      "competitive_landscape": 0.80,
      "data_availability": 0.85,
      "reproducibility": 0.85,
      "evidence_for": [
        {"claim": "GPR109A is a high-affinity receptor for niacin and butyrate (Kd ~100 nM)", "pmid": "11707776"},
        {"claim": "Microglia express functional GPR109A", "pmid": "25601787"},
        {"claim": "GPR109A activation suppresses microglial inflammation via HDAC-dependent mechanisms", "pmid": "26296954"},
        {"claim": "Oral butyrate improves neuroinflammation at μM plasma concentrations", "pmid": "27453500"},
        {"claim": "GPR109A agonists (niacin, acifran, MK-6892) have established SAR and multiple tool compounds", "pmid": "29307019"},
        {"claim": "No CNS-focused GPR109A program exists - open competitive field", "pmid": "30816739"}
      ],
      "evidence_against": [
        {"claim": "GPR109A-independent HDAC inhibition may contribute to therapeutic effects", "pmid": "28629854"},
        {"claim": "Niacin's side effects (flushing, hepatotoxicity) may limit therapeutic window", "pmid": "29947770"}
      ],
      "key_insight": "Resolves the nM-μM vs mM disconnect - GPR109A operates at concentrations achievable via oral supplementation while HDAC inhibition requires unachievable concentrations. This represents a paradigm shift, not a contradiction."
    },
    {
      "rank": 2,
      "id": "H2",
      "title": "Prebiotic Enhancement of SCFA Production",
      "target": "Microbial butyrate synthesis pathway (butyryl-CoA:acetate CoA-transferase, but gene cluster)",
      "composite_score": 0.445,
      "mechanistic_plausibility": 0.55,
      "evidence_strength": 0.50,
      "novelty": 0.45,
      "feasibility": 0.40,
      "therapeutic_potential": 0.35,
      "druggability": 0.15,
      "safety_profile": 0.75,
      "competitive_landscape": 0.25,
      "data_availability": 0.70,
      "reproducibility": 0.40,
      "

Voting as anonymous. Sign in to attribute your signals.

tokens

Replication

No replications yet

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.